NICHD23317.pdf

INTRODUCTION

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO

AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR

OPEN COMPETITION. The National Institutes of Health, National Institute of Child Health and Development (NICHD), in support of the work of the National Institute of Diabetes, Digestive, and Kidney Disease (NIDDK), intends to award a purchase order without providing for full and open competition (Including brand-name) to Illumina, Inc. to procure NovaSeq X Series 10B Reagent Kit (100 Cycle).

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE

The intended procurement is classified under NAICS code 325414 with a Size Standard 1250.

REGULATORY AUTHORITY

The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Regulation (FAR) Circular (FAC) 2023-04 effective 06/02/2023. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($250,000) and FAR Subpart 12- Acquisition of Commercial Items.

STATUTORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13—Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6— Competition Requirements.

Place of Performance National Institutes of Health 9000 Rockville Pike Bethesda MD 20892 United States

DESCRIPTION OF REQUIREMENT

The present protocol, The Natural History of Familial Carcinoid Tumor, involves the analysis of both germline and tumor DNA and RNA. Recent advances in next generation sequencing technologies offer genome-wide analysis with relatively low cost. A main goal of the research program is to determine the genetic mutation responsible for the disease. A major approach is to sequence affected family members in search of a common genetic mutation that is also not present in unaffected family members. This sequence information may also be used in linkage analysis of the affected family.

REQUIRED FEATURES AND SPECIFICATIONS

This requirement is to procure NMovaSeq X Series 10B Reagent Kits (100 Cycle).

Reagents for whole genome sequencing needed to sequence 140 individuals.

NovaSeq X Series 10B Reagent Kit (100 Cycle) This reagent kit provides one NovaSeq X Series 10B flow cell (with 8- lanes) and reagent consumables to support a single flow cell 100 cycles run on the NovaSeq X and NovaSeq X Plus systems.

These reagent kits are sole source because they can only be used on the NovaSeq X series sequencer manufactured by Illumina

TASK AREAS

Task Area 1 – Delivery Timelines – Contractor shall deliver the described supplies no later than 60-days after receipt of award.

Task Area 2 Shipping- The contractor shall ship equipment to National Institutes of Health, NIDDK, 9000 Rockville Pike, Maryland 20892.

CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION

(INCLUDING BRAND- NAME) DETERMINATION

The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10—Market Research. Only one source is available: Per FAR 13.106- 1(b)(1) the Contracting Officer has determined that Illumina is the only vendor that can provide the NMovaSeq X Series 10B Reagent Kits (100 Cycle).

CLOSING STATEMENT

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice.

Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provided feedback to respondents with respect to any information submitted. Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement, unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Vendor/Contractor’s (UEI) the Unique Entity ID from SAM.gov is now the authoritative identifier for those doing business with the federal government. The DUNS Number is no longer valid for federal award identification, the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.”

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

All responses to this notice (NICHD-23-317) shall be submitted electronically by 9:00 AM Eastern Standard Time, on August 23, 2023.

http://www.sam.gov/